Vanguard Group Inc Dr Reddys Laboratories LTD Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Vanguard Group Inc holds 1,019,011 shares of RDY stock, worth $73.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,019,011
Previous 1,038,258
1.85%
Holding current value
$73.2 Million
Previous $72.2 Million
3.46%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RDY
# of Institutions
242Shares Held
23.6MCall Options Held
25.2KPut Options Held
8.5K-
Black Rock Inc. New York, NY2.18MShares$156 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A62.16MShares$155 Million0.04% of portfolio
-
Robeco Institutional Asset Management B.V.1.97MShares$142 Million0.32% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.93MShares$139 Million0.22% of portfolio
-
Goldman Sachs Group Inc New York, NY1.56MShares$112 Million0.02% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $11.9B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...